Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harsh Dweep

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Mbio|April 21, 2021
COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune FunctionsOpeyemi S Adeniji, Leila B Giron, Mansi Purwar, et al.
Nature Communications|January 20, 2024
Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicityXue Zhang, Shishir M Pant, Cecily C Ritch, et al.
Frontiers in Immunology|October 21, 2021
Corrigendum: Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 PatientsLeila B Giron, Harsh Dweep, Xiangfan Yin, et al.
Frontiers in Immunology|June 28, 2021
Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 PatientsLeila B Giron, Harsh Dweep, Xiangfan Yin, et al.
The Journal of Experimental Medicine|February 10, 2021
Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing miceFilippo Veglia, Ayumi Hashimoto, Harsh Dweep, et al.
Ebiomedicine|July 14, 2019
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodesMariane H Schleimann, Maria-Louise Kobberø, Line K Vibholm, et al.
Scientific Reports|November 2, 2017
miR-16 and miR-103 impact 5-HT<sub>4</sub> receptor signalling and correlate with symptom profile in irritable bowel syndromeCarolin Wohlfarth, Stefanie Schmitteckert, Janina D Härtle, et al.
Nature Communications|January 13, 2021
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapyRajasekharan Somasundaram, Thomas Connelly, Robin Choi, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Mbio|April 21, 2021
COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune FunctionsOpeyemi S Adeniji, Leila B Giron, Mansi Purwar, et al.
Nature Communications|January 20, 2024
Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicityXue Zhang, Shishir M Pant, Cecily C Ritch, et al.
Frontiers in Immunology|October 21, 2021
Corrigendum: Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 PatientsLeila B Giron, Harsh Dweep, Xiangfan Yin, et al.
Frontiers in Immunology|June 28, 2021
Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 PatientsLeila B Giron, Harsh Dweep, Xiangfan Yin, et al.
The Journal of Experimental Medicine|February 10, 2021
Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing miceFilippo Veglia, Ayumi Hashimoto, Harsh Dweep, et al.
Ebiomedicine|July 14, 2019
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodesMariane H Schleimann, Maria-Louise Kobberø, Line K Vibholm, et al.
Scientific Reports|November 2, 2017
miR-16 and miR-103 impact 5-HT<sub>4</sub> receptor signalling and correlate with symptom profile in irritable bowel syndromeCarolin Wohlfarth, Stefanie Schmitteckert, Janina D Härtle, et al.
Nature Communications|January 13, 2021
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapyRajasekharan Somasundaram, Thomas Connelly, Robin Choi, et al.
Pageof 4